Registration
W STRATEGIES, LLC for GENENTECH INC
Firm
Client
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Patent Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Health Issues HCR
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Patent Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Copyright/Patent/Trademark CPT
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Patent Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.